<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colon <z:mp ids='MP_0002038'>carcinoma</z:mp> is a common type of <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Mechanisms of its establishment and progression have been studying for several decades </plain></SENT>
<SENT sid="2" pm="."><plain>Aberrant activation of the canonical Wnt signaling is frequently observed in colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, expression of the "noncanonical" Wnt ligands is also detected in this type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>However, the implication of the noncanonical Wnt signaling in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) progression is still unclear </plain></SENT>
<SENT sid="5" pm="."><plain>Here, to elucidate the characteristic features of the noncanonical Wnt signaling activation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> the expression of the "noncanonical" ligand hWnt11 has been studied </plain></SENT>
<SENT sid="6" pm="."><plain>It was shown for the first time that expression of the hWnt11 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is accompanied by the alternative splicing </plain></SENT>
<SENT sid="7" pm="."><plain>The new hWnt11 isoform (hWnt11sp3) has been identified </plain></SENT>
<SENT sid="8" pm="."><plain>Unlike to hWnt11, this isoform is not secreted and lacks the ability to inhibit the canonical Wnt signaling </plain></SENT>
<SENT sid="9" pm="."><plain>Considering the canonical Wnt signaling inhibiting activity of hWnt11, different functional properties of the ligand and its isoform may reflect a special role of the alternative splicing in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, due to the difference in their functional properties an existence of several Wnt isoforms should be taken into account for the investigation of the role of Wnt ligands </plain></SENT>
</text></document>